SCHEMBL8068659

SCHEMBL8068659

COc1cc2c(O)nc(-c3cccs3)nc2c(OC)c1OC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.47
▸ SMN1; SMN2 Q16637 6/20 0.47
▸ IDO1 P14902 2/20 0.44
▸ TDO2 P48775 2/20 0.44
▸ LMNA P02545 5/20 0.44
▸ KDM4E B2RXH2 5/20 0.44
▸ MAPT P10636 5/20 0.44
▸ HSD17B10 Q99714 3/20 0.44
▸ HPGD P15428 3/20 0.44
▸ MAPK1 P28482 3/20 0.44
▸ TP53 P04637 2/20 0.44
▸ NPSR1 Q6W5P4 2/20 0.44
▸ HTT P42858 2/20 0.44
▸ USP2 O75604 1/20 0.44
▸ F2 P00734 1/20 0.44
▸ ALOX15 P16050 1/20 0.44
▸ TSHR P16473 1/20 0.44
▸ RPS6KB2 Q9UBS0 2/20 0.44
▸ GAA P10253 1/20 0.43
▸ MEN1 O00255 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8070457 0.86 ALDH1A1 (0.48) ALDH1A1SMN1; SMN2IDO1TDO2LMNA
SCHEMBL8073660 0.81 KDM4E (0.44) ALDH1A1SMN1; SMN2IDO1TDO2LMNA
SCHEMBL8070339 0.81 RPS6KB2 (0.57) ALDH1A1SMN1; SMN2IDO1TDO2LMNA
SCHEMBL5259174 0.75 PDE5A (0.44) SMN1; SMN2LMNAMAPTTP53MEN1
SCHEMBL7304349 0.74 RAB9A (0.47) ALDH1A1SMN1; SMN2IDO1TDO2LMNA
SCHEMBL11213463 0.73 PDE5A (0.49) KDM4EMAPTGAAPKMTUBB4A
SCHEMBL8073867 0.73 ALDH1A1 (0.38) ALDH1A1SMN1; SMN2IDO1TDO2LMNA
SCHEMBL8068649 0.73 HSD17B10 (0.69) ALDH1A1SMN1; SMN2IDO1TDO2LMNA
SCHEMBL8059785 0.72 KDM4E (0.55) ALDH1A1SMN1; SMN2LMNAKDM4EMAPT
SCHEMBL8070560 0.72 KDM4E (0.52) ALDH1A1SMN1; SMN2LMNAKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6150372-A IMMUNOINFLAMMATORY AND AUTOIMMUNE DISEASES; BLOCKING INTRACELLULAR SIGNAL TRANSDUCTION AND ACTIVATION OF TRANSCRIPTION FACTORS; KINASE INHIBITORS; ANTIARTHRITIC, ISCHEMIC AGENTS, MULTIPLE SCLEROSIS, TRANSPLANT REJECTION SIGNAL PHARMACEUTICALS, INC. (US) 2000-11-21 — — US disclosed
US-5939421-A TREATMENT OF IMMUNOINFLAMMATORY AND AUTOIMMUNE DISEASES SUCH AS RHEUMATOID ARTHRITIS, TRANSPLANT REJECTION; INHIBIT KINASE(S) THAT REGULATE ACTIVATION OF TRANSCRIPTION FACTORS TO PREVENT PRODUCTION OF INFLAMMATORY PROTEINS SIGNAL PHARMACEUTICALS, INC. (US) 1999-08-17 — — US disclosed
WO-1999001441-A1 QUINAZOLINE ANALOGS AND RELATED COMPOUNDS AND METHODS FOR TREATING INFLAMMATORY CONDITIONS SIGNAL PHARMACEUTICALS, INC. (US) 1999-01-14 — — WO disclosed
Send feedback